The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production

Shuji Matsuda, Luca Giliberto, Yukiko Matsuda, Peter Davies, Eileen McGowan, Fiona Pickford, Jorge Ghiso, Blas Frangione, Luciano D'Adamio

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Alzheimer disease (AD), the most common senile dementia, is characterized by amyloid plaques, vascular amyloid, neurofibrillary tangles, and progressive neurodegeneration. Amyloid is mainly composed by amyloid-β (Aβ) peptides, which are derive from processing of the β-amyloid precursor protein (APP), better named amyloid-β precursor protein (AβPP), by secretases. The AβPP intracellular domain (AID), which is released together with Aβ, has signaling function, since it modulates apoptosis and transcription. Despite its biological and pathological importance, the mechanisms regulating AβPP processing are poorly understood. As cleavage of other γ-secretase substrates is regulated by membrane bound proteins, we have postulated the existence of integral membrane proteins that bind AβPP and regulate its processing. Here, we show that BRI2, a type II membrane protein, interacts with AβPP. Interestingly, 17 amino acids corresponding to the NH2-terminal portion of Aβ are necessary for this interaction. Moreover, BRI2 expression regulates AβPP processing resulting in reduced Aβ and AID levels. Altogether, these findings characterize the BRI2-AβPP interaction as a regulatory mechanism of AβPP processing that inhibits Aβ production. Notably, BRI2 mutations cause familial British (FBD) and Danish dementias (FDD) that are clinically and pathologically similar to AD. Finding that BRI2 pathogenic mutations alter the regulatory function of BRI2 on AβPP processing would define dysregulation of AβPP cleavage as a pathogenic mechanism common to AD, FDD, and FBD.

Original languageEnglish (US)
Pages (from-to)28912-28916
Number of pages5
JournalJournal of Biological Chemistry
Volume280
Issue number32
DOIs
StatePublished - Aug 12 2005
Externally publishedYes

Fingerprint

Amyloid beta-Protein Precursor
Amyloid
Dementia
Genes
Alzheimer Disease
Processing
Amyloid Precursor Protein Secretases
Membrane Proteins
Mutation
Neurofibrillary Tangles
Amyloid Plaques
Transcription
Blood Vessels
Apoptosis
Amino Acids
Peptides
Membranes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Matsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., ... D'Adamio, L. (2005). The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production. Journal of Biological Chemistry, 280(32), 28912-28916. https://doi.org/10.1074/jbc.C500217200

The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production. / Matsuda, Shuji; Giliberto, Luca; Matsuda, Yukiko; Davies, Peter; McGowan, Eileen; Pickford, Fiona; Ghiso, Jorge; Frangione, Blas; D'Adamio, Luciano.

In: Journal of Biological Chemistry, Vol. 280, No. 32, 12.08.2005, p. 28912-28916.

Research output: Contribution to journalArticle

Matsuda, S, Giliberto, L, Matsuda, Y, Davies, P, McGowan, E, Pickford, F, Ghiso, J, Frangione, B & D'Adamio, L 2005, 'The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production', Journal of Biological Chemistry, vol. 280, no. 32, pp. 28912-28916. https://doi.org/10.1074/jbc.C500217200
Matsuda, Shuji ; Giliberto, Luca ; Matsuda, Yukiko ; Davies, Peter ; McGowan, Eileen ; Pickford, Fiona ; Ghiso, Jorge ; Frangione, Blas ; D'Adamio, Luciano. / The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 32. pp. 28912-28916.
@article{eb72520d9dc441698501d55df01a4efa,
title = "The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production",
abstract = "Alzheimer disease (AD), the most common senile dementia, is characterized by amyloid plaques, vascular amyloid, neurofibrillary tangles, and progressive neurodegeneration. Amyloid is mainly composed by amyloid-β (Aβ) peptides, which are derive from processing of the β-amyloid precursor protein (APP), better named amyloid-β precursor protein (AβPP), by secretases. The AβPP intracellular domain (AID), which is released together with Aβ, has signaling function, since it modulates apoptosis and transcription. Despite its biological and pathological importance, the mechanisms regulating AβPP processing are poorly understood. As cleavage of other γ-secretase substrates is regulated by membrane bound proteins, we have postulated the existence of integral membrane proteins that bind AβPP and regulate its processing. Here, we show that BRI2, a type II membrane protein, interacts with AβPP. Interestingly, 17 amino acids corresponding to the NH2-terminal portion of Aβ are necessary for this interaction. Moreover, BRI2 expression regulates AβPP processing resulting in reduced Aβ and AID levels. Altogether, these findings characterize the BRI2-AβPP interaction as a regulatory mechanism of AβPP processing that inhibits Aβ production. Notably, BRI2 mutations cause familial British (FBD) and Danish dementias (FDD) that are clinically and pathologically similar to AD. Finding that BRI2 pathogenic mutations alter the regulatory function of BRI2 on AβPP processing would define dysregulation of AβPP cleavage as a pathogenic mechanism common to AD, FDD, and FBD.",
author = "Shuji Matsuda and Luca Giliberto and Yukiko Matsuda and Peter Davies and Eileen McGowan and Fiona Pickford and Jorge Ghiso and Blas Frangione and Luciano D'Adamio",
year = "2005",
month = "8",
day = "12",
doi = "10.1074/jbc.C500217200",
language = "English (US)",
volume = "280",
pages = "28912--28916",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "32",

}

TY - JOUR

T1 - The familial dementia BRI2 gene binds the alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production

AU - Matsuda, Shuji

AU - Giliberto, Luca

AU - Matsuda, Yukiko

AU - Davies, Peter

AU - McGowan, Eileen

AU - Pickford, Fiona

AU - Ghiso, Jorge

AU - Frangione, Blas

AU - D'Adamio, Luciano

PY - 2005/8/12

Y1 - 2005/8/12

N2 - Alzheimer disease (AD), the most common senile dementia, is characterized by amyloid plaques, vascular amyloid, neurofibrillary tangles, and progressive neurodegeneration. Amyloid is mainly composed by amyloid-β (Aβ) peptides, which are derive from processing of the β-amyloid precursor protein (APP), better named amyloid-β precursor protein (AβPP), by secretases. The AβPP intracellular domain (AID), which is released together with Aβ, has signaling function, since it modulates apoptosis and transcription. Despite its biological and pathological importance, the mechanisms regulating AβPP processing are poorly understood. As cleavage of other γ-secretase substrates is regulated by membrane bound proteins, we have postulated the existence of integral membrane proteins that bind AβPP and regulate its processing. Here, we show that BRI2, a type II membrane protein, interacts with AβPP. Interestingly, 17 amino acids corresponding to the NH2-terminal portion of Aβ are necessary for this interaction. Moreover, BRI2 expression regulates AβPP processing resulting in reduced Aβ and AID levels. Altogether, these findings characterize the BRI2-AβPP interaction as a regulatory mechanism of AβPP processing that inhibits Aβ production. Notably, BRI2 mutations cause familial British (FBD) and Danish dementias (FDD) that are clinically and pathologically similar to AD. Finding that BRI2 pathogenic mutations alter the regulatory function of BRI2 on AβPP processing would define dysregulation of AβPP cleavage as a pathogenic mechanism common to AD, FDD, and FBD.

AB - Alzheimer disease (AD), the most common senile dementia, is characterized by amyloid plaques, vascular amyloid, neurofibrillary tangles, and progressive neurodegeneration. Amyloid is mainly composed by amyloid-β (Aβ) peptides, which are derive from processing of the β-amyloid precursor protein (APP), better named amyloid-β precursor protein (AβPP), by secretases. The AβPP intracellular domain (AID), which is released together with Aβ, has signaling function, since it modulates apoptosis and transcription. Despite its biological and pathological importance, the mechanisms regulating AβPP processing are poorly understood. As cleavage of other γ-secretase substrates is regulated by membrane bound proteins, we have postulated the existence of integral membrane proteins that bind AβPP and regulate its processing. Here, we show that BRI2, a type II membrane protein, interacts with AβPP. Interestingly, 17 amino acids corresponding to the NH2-terminal portion of Aβ are necessary for this interaction. Moreover, BRI2 expression regulates AβPP processing resulting in reduced Aβ and AID levels. Altogether, these findings characterize the BRI2-AβPP interaction as a regulatory mechanism of AβPP processing that inhibits Aβ production. Notably, BRI2 mutations cause familial British (FBD) and Danish dementias (FDD) that are clinically and pathologically similar to AD. Finding that BRI2 pathogenic mutations alter the regulatory function of BRI2 on AβPP processing would define dysregulation of AβPP cleavage as a pathogenic mechanism common to AD, FDD, and FBD.

UR - http://www.scopus.com/inward/record.url?scp=23844491144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844491144&partnerID=8YFLogxK

U2 - 10.1074/jbc.C500217200

DO - 10.1074/jbc.C500217200

M3 - Article

C2 - 15983050

AN - SCOPUS:23844491144

VL - 280

SP - 28912

EP - 28916

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 32

ER -